scholarly journals THE MODULATING INFLUENCE OF CYCLIC NUCLEOTIDES UPON LYMPHOCYTE-MEDIATED CYTOTOXICITY

1973 ◽  
Vol 138 (2) ◽  
pp. 381-393 ◽  
Author(s):  
Terry B. Strom ◽  
Charles B. Carpenter ◽  
Marvin R. Garovoy ◽  
K. Frank Austen ◽  
John P. Merrill ◽  
...  
Keyword(s):  
Cyclic Amp ◽  
Adenylate Cyclase ◽  
Cyclic Gmp ◽  
Cyclic Nucleotides ◽  
Prostaglandin E1 ◽  
Cell Interaction ◽  
Target Cells ◽  
Cholinergic Stimulation ◽  
Initial Cell ◽  
Initial Interaction

The capacity of allosensitized thymus-derived lymphocytes to destroy target cells bearing donor alloantigens is modulated by the cellular levels of cyclic AMP and cyclic GMP. Increases in the cyclic AMP levels of attacking lymphocytes by stimulation with prostaglandin E1, isoproterenol, and cholera toxin inhibit lymphocyte-mediated cytotoxicity; whereas, depletion of cyclic AMP with imidazole enhances cytotoxicity. The augmentation of cytotoxicity produced by cholinergic stimulation with carbamylcholine is not associated with alterations in cyclic AMP levels and is duplicated by 8-bromo-cyclic GMP. The effects of activators of adenylate cyclase, cholinomimetic agents, and 8-bromocyclic GMP are upon the attacking and not the target cells and occur at the time of initial interaction of attacking and target cells. Indeed, the level of cyclic nucleotide (cyclic AMP and cyclic GMP) at the time of initial cell-to-cell interaction determines the extent of cytotoxicity.

scholarly journals Cyclic Nucleotides in Platelet Function

1977 ◽  
Author(s):  
R.J. Haslam
Keyword(s):  
Platelet Aggregation ◽  
Cyclic Amp ◽  
Adenylate Cyclase ◽  
Recent Work ◽  
Mechanism Of Action ◽  
Cyclic Gmp ◽  
Cyclic Nucleotides ◽  
Platelet Membrane ◽  
Phosphodiesterase 3 ◽  
Lines Of Evidence

Five lines of evidence indicate that cyclic AMP mediates the effects on platelets of inhibitory agonists, such as PGE1 and adenosine. Thus, these compounds activate adenylate cyclase in platelet particulate fractions (1) and increase cyclic AMP levels in intact platelets (2), while their effects are potentiated by inhibitors of cyclic AMP phosphodiesterase (3), are blocked by inhibitors of adenylate cyclase (4) and are mimicked by analogues of cyclic AMP (5). Apparent discrepancies between platelet cyclic AMP levels and the inhibition of aggregation can be explained by the ability of some aggregating agents to prevent increases in cyclic AMP and by postulating a delay before the effect of a change in platelet cyclic AMP level is expressed. A mechanism of action for cyclic AMP is suggested by observations that it causes phosphorylation of platelet membrane proteins and increases the uptake of Ca2+ ions by platelet membrane fractions. Studies on the effects of aggregating agents on cyclic AMP levels in resting platelets have given variable results but recent work indicating that compounds that can inhibit adenylate cyclase in intact platelets neither cause nor reproducibly potentiate aggregation or release suggests that cyclic AMP plays no role in the responses of platelets to aggregating agents, unless the platelet cyclic AMP level is elevated above resting values. Studies on platelet cyclic GMP levels have shown that increases usually occur in association with both platelet aggregation and the release reaction. While these findings are consistent with some role for cyclic GMP in these processes, conditions have been found in which some aggregation and release can occur without increases in cyclic GMP. In general, the available evidence suggests that Ca2+ ions are likely to be more important than cyclic GMP in mediating platelet responses.

Roles Of Cyclic Nucleotides In The Inhibition Of Platelet Function By Nitroprusside And By Ascorbate

1981 ◽  
Author(s):  
M M L Davidson ◽  
R J Haslam
Keyword(s):  
Cyclic Amp ◽  
Adenylate Cyclase ◽  
Platelet Function ◽  
Cyclic Gmp ◽  
Cyclic Nucleotides ◽  
Human Platelets ◽  
Dense Granule ◽  
Inhibitory Effects ◽  
Maximum Value ◽  
Induced Aggregation

The effects of nitroprusside and of ascorbate on the collagen-induced aggregation of washed human platelets and on the associated release of dense granule constituents were correlated with their effects on platelet cyclic GMP and cyclic AMP, which were measured either by radioimmunoassays or prelabelling methods. Nitroprusside at concentrations from 1 to 400 μM increased platelet cyclic GMP from 6 to 100-fold (maximum value approx. 50 pmol/109 platelets) and at concentrations above 10 μM also increased cyclic AMP about 2-fold (maximum value approx. 36 pmol/109 platelets). Platelet cyclic GMP reached a peak after an incubation period inversely related to the nitroprusside concentration and then declined. Collagen, which increased platelet cyclic GMP about 2-fold, enhanced the effect of nitroprusside on cyclic GMP but not cyclic AMP. Freshly prepared ascorbate (10 mM) increased platelet cyclic GMP about 8-fold. Storage of the ascorbate at pH 7 or simultaneous addition of 5 μM CuCl2 potentiated its action to give 15 to 20-fold increases in cyclic GMP and small increases in cyclic AMP. The results suggested that oxidation of the ascorbate was involved in these effects. In all the above studies, increases in platelet cyclic GMP greater than 6 to 10-fold were associated with measurable increases in cyclic AMP and with inhibitions of collagen-induced platelet responses that roughly correlated with the cyclic nucleotide changes. Addition of 100 μM 2',5'-dideoxyadenosine (an inhibitor of adenylate cyclase) blocked increases in platelet cyclic AMP but did not affect increases in cyclic GMP; this compound also decreased (but did not abolish) the inhibitory effects of nitroprusside and of ascorbate + CuCl2 These findings suggested roles for both cyclic GMP and cyclic AMP in mediating the inhibitions of platelet function by nitroprusside and ascorbate.

Cyclic nucleotides, calcium, bicarbonate, and protein secretion in canine pancreatic juice in response to cholecystokinin–pancreozymin

1979 ◽  
Vol 57 (6) ◽  
pp. 541-546 ◽  
Author(s):  
H. L. Cailla ◽  
H. Sarles ◽  
M. V. Singer
Keyword(s):  
Cyclic Amp ◽  
Pancreatic Juice ◽  
Cyclic Gmp ◽  
Cyclic Nucleotides ◽  
Parallel Increase ◽  
Calcium Bicarbonate ◽  
Strong Linear Correlation ◽  
Protein Output ◽  
Dose Dependent ◽  
Stimulation Of

The secretion of cyclic AMP, cyclic GMP, protein, calcium, and bicarbonate in the pancreatic juice of three nonanesthetized dogs with chronic gastric and duodenal Thomas cannulae has been studied. Intravenous infusions of increasing doses of cholecystokinin–pancreozymin (CCK) (1.5, 3, 6, 12, 24 Crick Harper-Raper (CHR) U kg−1 h−1) were administered together with a continuous submaximal dose of secretin (1 clinical unit (CU) kg−1 h−1). Doubling CCK doses every 45 min induced a parallel increase in the output of both cyclic nucleotides. Cyclic AMP output peaked at between 15 and 30 min for 3 and 6 U kg−1 h−1 of CCK and later for 12 and 24 U kg−1 h−1 of CCK whereas cyclic GMP output increased more constantly. Calcium output followed a pattern similar to that of cyclic GMP secretion. Flow rate and protein output attained their peaks at between 30 and 45 min. A strong linear correlation was found between the quantities of cyclic AMP, cyclic GMP, and the quantities of protein secreted in response to each CCK dose. This study demonstrates the presence of cyclic GMP in the canine pancreatic juice and the dose-dependent stimulation of the secretion of cyclic GMP and cyclic AMP by CCK in the presence of secretin.

Simple fluctuation of Ca2+ elicits the complex circadian dynamics of cyclic AMP and cyclic GMP in Paramecium

1999 ◽  
Vol 112 (2) ◽  
pp. 201-207 ◽  
Author(s):  
K. Hasegawa ◽  
H. Kikuchi ◽  
S. Ishizaki ◽  
A. Tamura ◽  
Y. Tsukahara ◽  
...  
Keyword(s):  
Cyclic Amp ◽  
Adenylate Cyclase ◽  
Guanylate Cyclase ◽  
Cyclic Gmp ◽  
Concentration Camp ◽  
Dark Cycle ◽  
Camp Concentration ◽  
Mathematical Functions ◽  
Camp And Cgmp ◽  
Different Levels

The circadian dynamics of cyclic adenosine 3′,5′-monophosphate (cAMP) and cyclic guanosine 3′,5′-monophosphate (cGMP) were simulated in Paramecium multimicronucleatum. The mathematical functions determined closely mimic the Ca2+ dependence of adenylate cyclase (AC) and guanylate cyclase (GC) activities as documented in P. tetraurelia. Patterns of cAMP concentration ([cAMP]), cGMP concentration ([cGMP]), and the ratio [cGMP]/[cAMP] were calculated with respect to Ca2+ concentrations ([Ca2+]) fluctuating sinusoidally with a period of 24 hours at three different levels: low, medium, and high. The functions displayed varying patterns of [cAMP] characteristic for [Ca2+] fluctuating at each level, while patterns of [cGMP] and [cGMP]/[cAMP] almost paralleled [Ca2+] fluctuations. Similar patterns were observed for actual [cAMP] and [cGMP] measured during the light/dark cycle in P. multimicronucleatum, grown in axenic media additionally containing [Ca2+] at 25 (low), 100 (medium), or 400 (high) microM, respectively. The coincidence between simulated and measured fluctuations of [cAMP] and [cGMP] suggests that the circadian fluctuations of intracellular [Ca2+] primarily stimulate activities of AC and GC via their different degrees of Ca2+ dependence, which are ultimately responsible for the circadian spatiotemporal organization of various physiological functions in Paramecium.

scholarly journals Special Issue on “New Advances in Cyclic AMP Signalling”—An Editorial Overview

Cells ◽  
2020 ◽  
Vol 9 (10) ◽  
pp. 2274
Author(s):  
Stephen John Yarwood
Keyword(s):  
Cyclic Amp ◽  
Adenylate Cyclase ◽  
Cyclic Nucleotides ◽  
Adenosine Monophosphate ◽  
Mechanisms Of Action ◽  
Effector Proteins ◽  
Cell Type ◽  
Special Issue ◽  
New Techniques ◽  
Cell Type Specific

The cyclic nucleotides 3′,5′-adenosine monophosphate (cyclic AMP) signalling system underlies the control of many biological events and disease processes in man. Cyclic AMP is synthesised by adenylate cyclase (AC) enzymes in order to activate effector proteins and it is then degraded by phosphodiesterase (PDE) enzymes. Research in recent years has identified a range of cell-type-specific cyclic AMP effector proteins, including protein kinase A (PKA), exchange factor directly activated by cyclic AMP (EPAC), cyclic AMP responsive ion channels (CICs), and the Popeye domain containing (POPDC) proteins, which participate in different signalling mechanisms. In addition, recent advances have revealed new mechanisms of action for cyclic AMP signalling, including new effectors and new levels of compartmentalization into nanodomains, involving AKAP proteins and targeted adenylate cyclase and phosphodiesterase enzymes. This Special Issue contains 21 papers that highlight advances in our current understanding of the biology of compartmentlised cyclic AMP signalling. This ranges from issues of pathogenesis and associated molecular pathways, functional assessment of novel nanodomains, to the development of novel tool molecules and new techniques for imaging cyclic AMP compartmentilisation. This editorial aims to summarise these papers within the wider context of cyclic AMP signalling.

scholarly journals The Role of Cyclic Nucleotides in the CNS

1977 ◽  
Vol 4 (3) ◽  
pp. 151-195 ◽  
Author(s):  
John W. Phillis
Keyword(s):  
Cyclic Amp ◽  
Synaptic Transmission ◽  
Cyclic Gmp ◽  
Adenosine Receptor ◽  
Cyclic Nucleotides ◽  
Phosphodiesterase Inhibitors ◽  
Adenosine Uptake ◽  
Injection Techniques ◽  
Firm Basis

SUMMARY:On the basis of the information presented in this review, it is difficult to reach any firm decision regarding the role of cyclic AMP (or cyclic GMP) in synaptic transmission in the brain. While it is clear that cyclic nucleotide levels can be altered by the exposure of neural tissues to various neurotransmitters, it would be premature to claim that these nucleotides are, or are not, essential to the transmission process in the pre- or postsynaptic components of the synapse. In future experiments with cyclic AMP it will be necessary to consider more critically whether the extracellularly applied nucleotide merely provides a source of adenosine and is thus activating an extracellularly located adenosine receptor, or whether it is actually reaching the hypothetical sites at which it might act as a second messenger. The application of cyclic AMP by intracellular injection techniques should minimize this particular problem, although possibly at the expense of new difficulties. Prior blockade of the adenosine receptor with agents such as theophylline or adenine xylofuranoside may also assist in the categorization of responses to extracellularly applied cyclic AMP as being a result either of activation of the adenosine receptor or of some other mechanism. Ultimately, the development of highly specific inhibitors for adenylate cyclase should provide a firm basis from which to draw conclusions about the role of cyclic AMP in synaptic transmission. Similar considerations apply to the actions of cyclic GMP and the role of its synthesizing enzyme, guanylale cyclase.The use of phosphodiesterase inhibitors in studies on cyclic nucleotides must also be approached with caution. The diverse actions of many of these compounds, which include calcium mobilization and block of adenosine uptake, could account for many of the results that have been reported in the literature.

scholarly journals Growth hormone, cyclic nucleotides and the rapid control of translation in heart muscle

1975 ◽  
Vol 152 (3) ◽  
pp. 583-592 ◽  
Author(s):  
J Mowbray ◽  
J A Davies ◽  
D J Bates ◽  
C J Jones
Keyword(s):  
Growth Hormone ◽  
Protein Synthesis ◽  
Cyclic Amp ◽  
Cyclic Gmp ◽  
Cyclic Nucleotides ◽  
Cyclic Nucleotide ◽  
Precursor Pool ◽  
Growth Hormone Action ◽  
Constant Rate ◽  
The Individual

Perfused rat heart incorporated L-[14C]tyrosine into protein at a constant rate for up to 75 min. A purified bovine growth-hormone preparation (1 mug/ml) stimulated the incorporation to a new constant rate that was more than three times the control rate by 10 min after hormone addition to perfusate. The hormone, however, did not alter the intracellular tracer amino acid pool, and the relationship of this to the aminoacyl-tRNA precursor pool is discussed. It is concluded that the increased incorporation largely reflected a rapid increase in protein synthesis at the ribosomes. Measurements of cyclic nucleotide contents during the perfusion showed that these appeared to vary in a systematic way during the perfusion. This strands in contrast with the constant values given by several other parameters measured in this preparation. Futher, the cyclic nucleotide variation seems to be independent of external effectors. The steady-state performance of the heart correlates more closely the [cyclic AMP]/[cyclic GMP] ratio than with the content of the individual cyclic nucleotides. At 10 min after the addition of growth hormone a slight decrese in cyclic AMP content and a large decrease in cyclic GMP were found, suggesting that the hormone's effect in stimulating protein synthesis may be mediated by a decrease in cyclic nucleotide concentrations or an increase in the [cyclic AMP]/[cyclic |p] ratio. The findings are also consistent with an intracellularly directed role for these nucleotides, and the possibility that the cyclic nucleotide changes are an indirect result of growth-hormone action is discussed.

scholarly journals IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNG

1972 ◽  
Vol 136 (3) ◽  
pp. 556-567 ◽  
Author(s):  
Michael Kaliner ◽  
Robert P. Orange ◽  
K. Frank Austen
Keyword(s):  
Cyclic Amp ◽  
Cyclic Gmp ◽  
Human Lung ◽  
Cyclic Adenosine Monophosphate ◽  
Adenosine Monophosphate ◽  
Guanosine Monophosphate ◽  
Target Cells ◽  
Human Lung Tissue ◽  
Adrenergic Agents ◽  
Protein Assay

The immunologic release of histamine and slow reacting substance of anaphylaxis (SRS-A) from human lung tissue can be enhanced by stimulation with either alpha adrenergic agents (phenylephrine or norepinephrine in the presence of propranolol) or cholinergic agents (acetylcholine or Carbachol). The finding that atropine prevents cholinergic but not comparable alpha adrenergic enhancement is consistent with the view that cholinergic and alpha adrenergic agonists interact with separate receptor sites on the target cells involved in the immunologic release of chemical mediators. The consistent qualitative relationship between the antigen-induced release of mediators and the level of cyclic adenosine monophosphate (cyclic AMP) as measured by the isolation of 14C-labeled cyclic AMP after incorporation of adenine-14C into the tissues or by the cyclic AMP binding protein assay suggests that changes in the level of this cyclic nucleotide mediate adrenergic modulation of the release of histamine and SRS-A. The addition of 8-bromo-cyclic guanosine monophosphate (cyclic GMP) produces an enhancement of the immunologic release of mediators while dibutyryl cyclic AMP is inhibitory. As cholinergic-induced enhancement was not associated with a measurable change in the levels of cyclic AMP, the possibility is suggested that cyclic GMP may be the intracellular mediator of cholinergic-induced enhancement of the immunologic release of histamine and SRS-A.

scholarly journals Evidence for the involvement of cyclic AMP in the pheromonal modulation of barnacle settlement

1995 ◽  
Vol 198 (3) ◽  
pp. 655-664 ◽  
Author(s):  
A Clare ◽  
R Thomas ◽  
D Rittschof
Keyword(s):  
Signal Transduction ◽  
Cyclic Amp ◽  
Adenylate Cyclase ◽  
Cyclic Gmp ◽  
Phosphodiesterase Inhibitor ◽  
Balanus Amphitrite ◽  
Dibutyryl Cyclic Amp ◽  
Physico Chemical ◽  
Miconazole Nitrate

The involvement of cyclic AMP in the settlement of the cypris larva of Balanus amphitrite amphitrite Darwin has been examined through the use of compounds that affect intracellular cyclic AMP levels. The activation of adenylate cyclase with forskolin, and the inhibition of phosphodiesterase with 3-isobutyl-1-methylxanthine, caffeine and theophylline, significantly increased the settlement of cyprids. Although the analogue dibutyryl cyclic AMP appeared to increase settlement, the effect was not significant. No marked increase in settlement resulted from the incubation of cyprids with dibutyryl cyclic GMP, 8-(4-chlorophenylthio) (CPT) cyclic AMP or papaverine (a phosphodiesterase inhibitor). Miconazole nitrate, an adenylate cyclase inhibitor, prevented settlement, but this effect appeared to be physico-chemical rather than pharmacological. Radioimmunoassay did not clearly show whether cyclic AMP levels changed following exposure of cyprids to a pulse of crude barnacle extract. However, exposure to forskolin significantly increased the cyclic AMP titre of cyprids. We conclude that compounds that alter intracellular cyclic AMP levels alter normal patterns of cyprid settlement. Whether this is because of an alteration in signal transduction is unclear.

Sign in / Sign up

Export Citation Format

Share Document